JPM
JPMorgan Chase & Co.
JPM has the edge over SCM overall, supported by stronger fundamentals and stronger modeled upside.
SCM
Stellus Capital Investment Corporation
SCM trails on the overall score without a compensating advantage in the available component scores.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
SCM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| N/A | |
| N/A |
SCM's profitability is currently healthy, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like SCM.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over SCM in the historical PE scenario, which offers more potential upside but is not a forecast.
SCM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 6.3x | $6.67 | — |
| Cheap | 7x | $4.07 | -39% |
| Fair | 10x | $5.85 | -12% |
| Current | 12x | $6.67 | — |
| Expensive | 20x | $11.34 | +70% |
Historical ranges are pointers, not guarantees.
SCM's PE is in its fair range at 12x. On analysts' estimates for next year's earnings, today's price would be 6.3x, in its cheap range.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
SCM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Stable | |
| Decline | |
| Improving | |
| Limited | |
| High |
Analysts expect SCM's profitability to improve, but its revenue to decline.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over SCM on earnings, with more consistent year-over-year improvement.
SCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.05 | +82% |
| Q3 2026 | $0.58 | -46% |
| Q2 2026 | $1.03 | -28% |
| Q1 2026 | $0.83 | -42% |
| Q4 2025 | $0.95 | -47% |
| Q3 2025 | $1.08 | -45% |
| Q2 2025 | $1.44 | +13% |
| Q1 2025 | $1.43 | +30% |
| Q4 2024 | $1.79 | +124% |
SCM's earnings per share have fallen from their peak: $0.58 over the past year, against $3.54 in early 2021.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the stronger quarterly revenue trend. Revenue is up 8.1% for JPM versus down 25% for SCM.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
SCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2022 | $8.7M | -25% |
| Q1 2022 | $11.8M | +2.2% |
| Q4 2021 | $17.9M | -17% |
| Q3 2021 | $20.4M | +56% |
| Q2 2021 | $11.6M | -74% |
| Q4 2020 | $21.6M | +199% |
SCM's revenue fell from its 2020 peak and has held roughly level since: $9M last quarter, down 25% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2022 | 22% | -27 points |
| Q1 2022 | 47% | +0.5 points |
| Q4 2021 | 66% | -12 points |
| Q3 2021 | 70% | +8.9 points |
| Q2 2021 | 49% | -40 points |
| Q1 2021 | 46% | N/A |
| Q4 2020 | 78% | +50 points |
| Q3 2020 | 61% | N/A |
SCM's operating margin was 22% last quarter, down 27 points from the same quarter a year ago, near the bottom of its range since 2019.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
SCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $957.1K | +$21.2M |
| Q2 2026 | $33.4M | +41% |
| Q1 2026 | $22.8M | +$59.7M |
| Q4 2025 | $9M | +$40.8M |
| Q3 2025 | -$20.2M | -272% |
| Q2 2025 | $23.7M | +$36.8M |
| Q1 2025 | -$36.9M | -928% |
| Q4 2024 | -$31.8M | -226% |
SCM has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over SCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
SCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -403K shares |
| 1 year | -0.1% | -14.8K shares |
| 3 years | +25% | +5.6M shares |
| 5 years | +46% | +9M shares |
| Available history | +47% | +9M shares |
SCM has 28M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.1M |
| Q2 2022 | — |
| Q1 2022 | — |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $2.00 |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
SCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2022 | 16.8x | High |
| Q1 2022 | 14.5x | High |
| Q4 2021 | 12.8x | High |
| Q3 2021 | 11.7x | High |
| Q2 2021 | 13.9x | High |
| Q1 2021 | 6.2x | High |
| Q4 2020 | 17.7x | High |
| Q3 2020 | 54.9x | High |
SCM's net debt is about 17 years of its operating earnings (EBITDA), up from 14 years a year ago. Net leverage isn't a meaningful measure for financial services companies like SCM.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
SCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.6 | Neutral |
| Stochastic | 18.1 | Oversold |
SCM's weekly RSI is 34 (neutral) and its Stochastic is 18 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
SCM PE vs Financial Services Sector
| Metric | SCM | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 12% below |
| PE % | 60 | 63 | 3 pts below |
SCM has the edge over JPM on valuation relative to its sector.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over SCM on trend strength, trading above more of its moving averages.
SCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.11 | 6.2% below |
| 20 week MA | $7.76 | 14% below |
| 50 week MA | $9.41 | 29% below |
| 100 week MA | $11.5 | 42% below |
| 200 week MA | $12.7 | 47% below |
SCM is in a downtrend: it's below all five of its weekly moving averages, and 47% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over SCM on returns for 2026, with the stronger performance.
SCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $14.5 | $10.7 | -26% |
| 2021 | $10.7 | $13.0 | +21% |
| 2022 | $13.0 | $13.0 | +0.5% |
| 2023 | $13.0 | $12.9 | -1.4% |
| 2024 | $12.9 | $13.8 | +7% |
| 2025 | $13.8 | $12.6 | -8.6% |
| 2026 YTD | $12.6 | $6.67 | -47% |
SCM has finished lower in three of the last six years. It's down 47% so far in 2026.